| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Joanne Curley last filed a Form 4 in September 2025, as Chief Development Officer at VERA. From May 2022 to August 2023, the filings on record show 0 open-market purchases and 18 sales. Joanne Curley's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Joanne Curley a middling insider score of 69/100, based on 21 past trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of +9.4%.
At the last filing, the largest reported position was 26,962 shares of VERA. The VERA filings lean toward selling, a net 102,669 shares.
Shares as reported in the last Form 4 for each company; the most recent is from September 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 8,539 | $19.13 | $163,389.06 | -22.3% | -12.5% | -0.7% | |
| Aug 3, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sell | 988 | $16.81 | $16,608.28 | -5.4% | +4.6% | +3.8% | |
| Jul 19, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 11,444 | $16.01 | $183,271.09 | -38.5% | +21.7% | +2.5% | |
| Jul 14, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 9,104 | $15.14 | $137,863.71 | -33.3% | +28.9% | +9.4% | |
| Jul 7, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 9,666 | $15.05 | $145,453.39 | -31.5% | +40.4% | +7.2% | |
| Jun 22, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 1,545 | $15.01 | $23,197.95 | -6.1% | +47.0% | +10.8% | |
| Jun 17, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 5,887 | $15.04 | $88,565.49 | -19.7% | +53.5% | -7.5% | |
| May 31, 2022 | VERA Vera Therapeutics, Inc. | Chief Development Officer | Sale+OE | 400 | $15.22 | $6,086.20 | -1.6% | +50.1% | -42.6% |